133 related articles for article (PubMed ID: 35579094)
1. Health-related quality of life in patients with mixed connective tissue disease: a comparison with matched systemic sclerosis patients.
Abouyahya I; Liem SIE; Amoura Z; Fonseca JE; Chaigne B; Cutolo M; Doria A; Fischer-Betz R; Guimaraes V; Huizinga TWJ; van Laar JM; Martin T; Matucci-Cerinic M; Montecucco C; Schneider M; Smith V; Müller-Ladner U; de Vries-Bouwstra JK
Clin Exp Rheumatol; 2022 May; 40 Suppl 134(5):66-70. PubMed ID: 35579094
[TBL] [Abstract][Full Text] [Related]
2. Clinical Features of Systemic Sclerosis-Mixed Connective Tissue Disease and Systemic Sclerosis Overlap Syndromes.
Fairley JL; Hansen D; Proudman S; Sahhar J; Ngian GS; Walker J; Strickland G; Wilson M; Morrisroe K; Ferdowsi N; Major G; Roddy J; Stevens W; Nikpour M;
Arthritis Care Res (Hoboken); 2021 May; 73(5):732-741. PubMed ID: 32058672
[TBL] [Abstract][Full Text] [Related]
3. Health-related quality of life in patients with systemic sclerosis: evolution over time and main determinants.
van Leeuwen NM; Ciaffi J; Liem SIE; Huizinga TWJ; de Vries-Bouwstra JK
Rheumatology (Oxford); 2021 Aug; 60(8):3646-3655. PubMed ID: 33401302
[TBL] [Abstract][Full Text] [Related]
4. Radiological images of interstitial pneumonia in mixed connective tissue disease compared with scleroderma and polymyositis/dermatomyositis.
Yamanaka Y; Baba T; Hagiwara E; Yanagawa N; Takemura T; Nagaoka S; Sakai F; Kuwano K; Ogura T
Eur J Radiol; 2018 Oct; 107():26-32. PubMed ID: 30292269
[TBL] [Abstract][Full Text] [Related]
5. Associations between circulating endostatin levels and vascular organ damage in systemic sclerosis and mixed connective tissue disease: an observational study.
Reiseter S; Molberg Ø; Gunnarsson R; Lund MB; Aalokken TM; Aukrust P; Ueland T; Garen T; Brunborg C; Michelsen A; Abraityte A; Hoffmann-Vold AM
Arthritis Res Ther; 2015 Aug; 17(1):231. PubMed ID: 26315510
[TBL] [Abstract][Full Text] [Related]
6. Performance of the 2013 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Systemic Sclerosis (SSc) in large, well-defined cohorts of SSc and mixed connective tissue disease.
Hoffmann-Vold AM; Gunnarsson R; Garen T; Midtvedt Ø; Molberg Ø
J Rheumatol; 2015 Jan; 42(1):60-3. PubMed ID: 25274890
[TBL] [Abstract][Full Text] [Related]
7. Nailfold capillaroscopy and autoimmune connective tissue diseases in patients from a Portuguese nailfold capillaroscopy clinic.
Bernardino V; Rodrigues A; Lladó A; Panarra A
Rheumatol Int; 2020 Feb; 40(2):295-301. PubMed ID: 31451935
[TBL] [Abstract][Full Text] [Related]
8. The HLA profiles of mixed connective tissue disease differ distinctly from the profiles of clinically related connective tissue diseases.
Flåm ST; Gunnarsson R; Garen T; ; Lie BA; Molberg Ø
Rheumatology (Oxford); 2015 Mar; 54(3):528-35. PubMed ID: 25187641
[TBL] [Abstract][Full Text] [Related]
9. Mixed Connective Tissue Disease as Different Entity: Global Methylation Aspect.
Filipowicz G; Wajda A; Stypińska B; Kmiołek T; Felis-Giemza A; Stańczyk S; Czuszyńska Z; Walczyk M; Olesińska M; Paradowska-Gorycka A
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37895173
[TBL] [Abstract][Full Text] [Related]
10. Longitudinal follow-up of mixed connective tissue disease and overlapping autoimmune diseases of childhood onset in the Afro-descendant population of the French West Indies.
Felix A; Osei L; Delion F; Suzon B; Abel A; Drame M; Hatchuel Y; Deligny C; Louis-Sidney F
Pediatr Rheumatol Online J; 2024 Jan; 22(1):13. PubMed ID: 38212775
[TBL] [Abstract][Full Text] [Related]
11. Long-term follow-up of nailfold videocapillaroscopic microvascular parameters in mixed connective tissue disease versus systemic sclerosis patients: a retrospective cohort study.
Paolino S; Ferrari G; Pizzorni C; Patanè M; Smith V; Cutolo M; Sulli A
Clin Exp Rheumatol; 2019; 37 Suppl 119(4):102-107. PubMed ID: 31587695
[TBL] [Abstract][Full Text] [Related]
12. Outcome of pregnancies complicated by systemic sclerosis and mixed connective tissue disease.
Chung L; Flyckt RL; Colón I; Shah AA; Druzin M; Chakravarty EF
Lupus; 2006; 15(9):595-9. PubMed ID: 17080915
[TBL] [Abstract][Full Text] [Related]
13. Pediatric mixed connective tissue disease versus other overlap syndromes: a retrospective multicenter cohort study.
Batu ED; Günalp A; Şahin S; Özdel S; Kızıldağ Z; Pac Kısaarslan A; Bağrul İ; Kasap Cuceoglu M; Tanatar A; Sonmez HE; Sag E; Demir S; Çelikel E; Cağlayan S; Çelikel Acar B; Sözeri B; Aktay Ayaz N; Bilginer Y; Poyrazoğlu MH; Ünsal E; Kasapçopur Ö; Özen S
Rheumatol Int; 2023 Aug; 43(8):1485-1495. PubMed ID: 36906866
[TBL] [Abstract][Full Text] [Related]
14. Health-related quality of life in systemic sclerosis compared with other rheumatic diseases: a cross-sectional study.
Park EH; Strand V; Oh YJ; Song YW; Lee EB
Arthritis Res Ther; 2019 Feb; 21(1):61. PubMed ID: 30770765
[TBL] [Abstract][Full Text] [Related]
15. Lung function is associated with minimal EQ-5D changes over time in patients with systemic sclerosis.
Ciaffi J; van Leeuwen NM; Liem SIE; Ninaber MK; Huizinga TWJ; de Vries-Bouwstra JK
Clin Rheumatol; 2020 May; 39(5):1543-1549. PubMed ID: 31980971
[TBL] [Abstract][Full Text] [Related]
16. In-depth characterization of pulmonary arterial hypertension in mixed connective tissue disease: a French national multicentre study.
Chaigne B; Chevalier K; Boucly A; Agard C; Baudet A; Bourdin A; Chabanne C; Cottin V; Fesler P; Goupil F; Jego P; Launay D; Lévesque H; Maurac A; Mohamed S; Tromeur C; Rottat L; Sitbon O; Humbert M; Mouthon L
Rheumatology (Oxford); 2023 Oct; 62(10):3261-3267. PubMed ID: 36727465
[TBL] [Abstract][Full Text] [Related]
17. Scleroderma overlap syndromes.
Jablonska S; Blaszczyk M
Adv Exp Med Biol; 1999; 455():85-92. PubMed ID: 10599327
[TBL] [Abstract][Full Text] [Related]
18. Clinical features of patients with juvenile onset mixed connective tissue disease: analysis of data collected in a nationwide collaborative study in Japan.
Kotajima L; Aotsuka S; Sumiya M; Yokohari R; Tojo T; Kasukawa R
J Rheumatol; 1996 Jun; 23(6):1088-94. PubMed ID: 8782145
[TBL] [Abstract][Full Text] [Related]
19. The enigma of mixed connective tissue disease-challenges in routine care.
Wanzenried A; Garaiman A; Jordan S; Distler O; Maurer B
Clin Rheumatol; 2022 Nov; 41(11):3503-3511. PubMed ID: 35902486
[TBL] [Abstract][Full Text] [Related]
20. Effects of rituximab in connective tissue disorders related interstitial lung disease.
Lepri G; Avouac J; Airò P; Anguita Santos F; Bellando-Randone S; Blagojevic J; Garcia Hernàndez F; Gonzalez Nieto JA; Guiducci S; Jordan S; Limaye V; Maurer B; Selva-O'Callaghan A; Riccieri V; Distler O; Matucci-Cerinic M; Allanore Y
Clin Exp Rheumatol; 2016; 34 Suppl 100(5):181-185. PubMed ID: 27749242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]